news releases
FOR: PYNG TECHNOLOGIES CORP.
VSE SYMBOL: PYT
MAY 29, 1998
Pyng Technologies US Military Evaluation Procedure
Received and Training Schedule Confirmed
VANCOUVER, BRITISH COLUMBIA--Pyng Technologies Corp. is pleased to
announce that Pyng Medical Corp. has received from the Walter Reid
Army Institute of Research a draft evaluation procedure for Adult
Intraosseous Infusion Systems.
The Intraosseous Infusion system evaluation has been officially
requested by the US Army Special Operations Command and will be
conducted by the Chief, Combat Trauma Research. The Army Institute
of Research will be conducting a comparative evaluation of
F.A.S.T. 1, The Jamshidi Needle, The Sur-Fast, and The B.I.G. The
F.A.S.T 1 System is the only FDA approved system for accessing the
central vascular system via Intraosseous Infusion in the sternum.
Pyng Medical Corp. has worked extensively with the US Military
during the development of the F.A.S.T 1 System to ensure that the
System meets the required needs of medics in a battlefield
environment.
Pyng Medical Corp. will be sending Dr. David Johnson, Vice
President of Research and Development and Judy Findlay, Vice
President of Engineering to Walter Reid Army Institute of research
to train the Special Operations personnel so that the evaluation
can begin.
Pyng Medical Corp. anticipates that the evaluation should be
completed in June.
2nd news release
FOR: PYNG TECHNOLOGIES CORP.
VSE SYMBOL: PYT
MAY 29, 1998
Pyng Technologies Agreement Reached With Arizona Heart
and Maricopa Hospitals in Phoenix, Arizona
VANCOUVER, BRITISH COLUMBIA--Pyng Technologies Corp. is pleased to
announce that subsidiary Pyng Medical Corp. has reached agreement
with Arizona Heart Hospital and Maricopa Hospital in Phoenix,
Arizona to use the F.A.S.T 1 System for Adult Intraosseous
Infusion. The F.A.S.T. 1 will be used in their emergency
departments and in the operating room in the Arizona Heart
Hospital.
This is important news for Pyng Medical Corp. because Arizona
Heart and Maricopa emergency departments also serve as the
research arm of Rural / Metro Corporation which is the second
largest ambulance service in America.
Arizona Heart Hospital, America's newest high technology heart
hospital, which expects that it will do 1500 heart operations per
year, has also agreed to use the F.A.S.T 1 System prior to open
chest surgery in order to evaluate the device and protocol.
Pyng Medical Corp., as part of its future marketing program,
intends to provide the Emergency Medical Community with a large
body of medical evidence on the effectiveness of the F.A.S.T 1
System to gain rapid, safe, and assured vascular access. This
agreement, along with others that have been reached, will enable
Pyng Medical Corp. to fast track the field trial data collection
process that is now underway because of the extended use of the
F.A.S.T 1 System in both Maricopa and Arizona Heart Hospitals.
All data will be submitted to Pyng Medical Corp. and will be
published as appropriate by Pyng Medical Corp. and Dr. Charles V.
Pollack Jr. Chairman, and Dr. Brian Tiffany Co-Director of
Research at Arizona Heart and Maricopa Hospitals.
-30-
FOR FURTHER INFORMATION PLEASE CONTACT:
Pyng Technologies Corp.
Michael W. Jacobs
President
1-800-349-7834
Website: pyng.com |
